• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌治疗后的疼痛、感觉障碍和心理困扰是常见后遗症:一项横断面研究。

Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study.

作者信息

Mertz Birgitte Goldschmidt, Duriaud Helle Molter, Kroman Niels, Andersen Kenneth Geving

机构信息

a Breast Surgery Section , Rigshospitalet, Copenhagen University Hospital , Denmark.

b Section for Surgical Pathophysiology, Rigshospitalet , Copenhagen , Denmark.

出版信息

Acta Oncol. 2017 May;56(5):724-729. doi: 10.1080/0284186X.2017.1295167. Epub 2017 Mar 2.

DOI:10.1080/0284186X.2017.1295167
PMID:28447566
Abstract

UNLABELLED

Sequelae such as pain, sensory disturbances and psychological distress are well known after treatment for invasive breast cancer (IBC). Patients treated for ductal carcinoma in situ (DCIS) receive a similar treatment as low-risk IBC. The aim of this cross-sectional study was to describe prevalence of postoperative pain, sensory disturbances, psychological distress and rehabilitation needs among Danish women with DCIS.

METHODS

A total of 574 women treated for DCIS in Denmark in 2013 and 2014 were enrolled and 473 (82%) completed a detailed questionnaire on demographic factors, pain, sensory disturbances, psychological aspects and rehabilitation needs 1-3 years after surgery.

RESULTS

Median age was 60 years. A total of 33% of patients reported any pain and 12% reported moderate to severe pain in the area of surgery. Younger age (<50 years OR 4.7 (95% CI: 1.6-14.0, p = 0.006)), aged 50 to 65 years OR 2.8 (95% CI: 1.1-7.0, p = 0.02) and anxiety and depression (measured by HADS >15 OR of 3.1 (95% CI: 1.5-6.3, p = 0.003)) were significantly associated with moderate to severe pain. Approximately one-third of the patients reported sensory disturbances such as pins and needles (32%), numbness (37%) and painful itch (30%) and 94 women (20%) reported anxiety ≥8, 26 (6%) depression and 51 (11%) reported distress.

CONCLUSIONS

This cross-sectional study showed that women treated for DCIS suffered from pain, sensory disturbances and psychological impairment and had unmet rehabilitation needs. Further research is warranted, specifically addressing rehabilitation after diagnosis and treatment of DCIS.

摘要

未标注

侵袭性乳腺癌(IBC)治疗后,疼痛、感觉障碍和心理困扰等后遗症是众所周知的。原位导管癌(DCIS)患者接受的治疗与低风险IBC患者相似。这项横断面研究的目的是描述丹麦DCIS女性患者术后疼痛、感觉障碍、心理困扰及康复需求的患病率。

方法

纳入2013年和2014年在丹麦接受DCIS治疗的574名女性,473名(82%)在术后1 - 3年完成了一份关于人口统计学因素、疼痛、感觉障碍、心理状况和康复需求的详细问卷。

结果

中位年龄为60岁。共有33%的患者报告有任何疼痛,12%的患者报告手术区域有中度至重度疼痛。年龄较小(<50岁,比值比[OR]为4.7[95%置信区间(CI):1.6 - 14.0,p = 0.006])、50至65岁(OR为2.8[95% CI:1.1 - 7.0,p = 0.02])以及焦虑和抑郁(通过医院焦虑抑郁量表[HADS]>15测量,OR为3.1[95% CI:1.5 - 6.3,p = 0.003])与中度至重度疼痛显著相关。约三分之一的患者报告有感觉障碍,如刺痛(32%)、麻木(37%)和瘙痒疼痛(30%),94名女性(20%)报告焦虑≥8分,26名(6%)报告抑郁,51名(11%)报告有困扰。

结论

这项横断面研究表明,接受DCIS治疗的女性存在疼痛、感觉障碍和心理损害,且康复需求未得到满足。有必要进行进一步研究,特别是针对DCIS诊断和治疗后的康复问题。

相似文献

1
Pain, sensory disturbances and psychological distress are common sequelae after treatment of ductal carcinoma in situ: a cross-sectional study.导管原位癌治疗后的疼痛、感觉障碍和心理困扰是常见后遗症:一项横断面研究。
Acta Oncol. 2017 May;56(5):724-729. doi: 10.1080/0284186X.2017.1295167. Epub 2017 Mar 2.
2
Pain, Sensory Disturbances, and Psychological Distress among Danish Women Treated for Ductal Carcinoma In Situ: An Exploratory Study.丹麦原位导管癌女性患者的疼痛、感觉障碍及心理困扰:一项探索性研究
Pain Manag Nurs. 2017 Oct;18(5):309-317. doi: 10.1016/j.pmn.2017.03.004. Epub 2017 Jun 8.
3
Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.与早期浸润性乳腺癌患者相比,患有导管原位癌的患者更易患重度抑郁症。
Breast Cancer Res Treat. 2018 Jan;167(1):205-213. doi: 10.1007/s10549-017-4495-y. Epub 2017 Sep 11.
4
Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.乳腺导管原位癌管理中的多学科共同决策
Ann Surg Oncol. 2015 Dec;22 Suppl 3(0 3):S516-21. doi: 10.1245/s10434-015-4607-z. Epub 2015 May 19.
5
The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.他汀类药物的靶点HMG-CoA还原酶在导管原位癌中表达,可能预测患者对放疗的反应。
Ann Surg Oncol. 2014 Sep;21(9):2911-9. doi: 10.1245/s10434-014-3708-4. Epub 2014 Apr 29.
6
Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.诊断为 DCIS 或浸润性乳腺癌后的一年中心理困扰和身体健康状况。
Breast Cancer Res Treat. 2010 Apr;120(3):685-91. doi: 10.1007/s10549-009-0477-z. Epub 2009 Aug 4.
7
Prevalence of and factors associated with persistent pain following breast cancer surgery.乳腺癌手术后持续性疼痛的患病率及相关因素。
JAMA. 2009 Nov 11;302(18):1985-92. doi: 10.1001/jama.2009.1568.
8
A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.导管原位癌和早期浸润性乳腺癌女性的风险认知与心理疾病比较。
Breast Cancer Res Treat. 2003 Feb;77(3):285-93. doi: 10.1023/a:1021853302033.
9
Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide.乳腺癌辅助化疗后持续疼痛、感觉障碍和功能障碍:环磷酰胺、表柔比星和氟尿嘧啶与多西紫杉醇+表柔比星和环磷酰胺的比较。
Acta Oncol. 2012 Nov;51(8):1036-44. doi: 10.3109/0284186X.2012.692884. Epub 2012 Jun 7.
10
Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.乳腺小叶原位癌(LCIS):其长期预后与导管原位癌(DCIS)相似吗?200例病例分析。
Radiat Oncol. 2015 May 6;10:110. doi: 10.1186/s13014-015-0379-7.

引用本文的文献

1
Quality of life issues in patients with ductal carcinoma in situ: a systematic review.导管原位癌患者的生活质量问题:系统评价。
Support Care Cancer. 2024 Oct 1;32(10):695. doi: 10.1007/s00520-024-08864-x.
2
Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis.《2022年癌症患者疼痛患病率最新情况:系统文献综述与荟萃分析》
Cancers (Basel). 2023 Jan 18;15(3):591. doi: 10.3390/cancers15030591.
3
Using Machine Vision of Glycolytic Elements to Predict Breast Cancer Recurrences: Design and Implementation.
利用糖酵解元件的机器视觉预测乳腺癌复发:设计与实现
Metabolites. 2022 Dec 27;13(1):41. doi: 10.3390/metabo13010041.
4
Pain Control After Mastectomy in Transgender Patients: Ultrasound-guided Pectoral Nerve Block II Versus Conventional Intercostal Nerve Block: A Randomized Clinical Trial.变性患者乳房切除术后的疼痛控制:超声引导下胸神经阻滞II与传统肋间神经阻滞的比较:一项随机临床试验
Anesth Pain Med. 2021 Nov 10;11(5):e119440. doi: 10.5812/aapm.119440. eCollection 2021 Oct.
5
Pain, numbness, or both? Distinguishing the longitudinal course and predictors of positive, painful neuropathic features vs numbness after breast cancer surgery.疼痛、麻木,还是两者皆有?区分乳腺癌手术后阳性、疼痛性神经病变特征与麻木的纵向病程及预测因素。
Pain Rep. 2021 Nov 22;6(4):e976. doi: 10.1097/PR9.0000000000000976. eCollection 2021 Nov-Dec.
6
Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators.使用生物心理社会疼痛调制物综合术前评估预测乳房手术后 12 个月的持续性疼痛严重程度和影响。
Ann Surg Oncol. 2021 Sep;28(9):5015-5038. doi: 10.1245/s10434-020-09479-2. Epub 2021 Jan 15.
7
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study.医护专业人员对主动监测在导管原位癌(DCIS)管理中作用的看法:定性访谈研究。
Breast. 2020 Dec;54:99-105. doi: 10.1016/j.breast.2020.09.002. Epub 2020 Sep 15.
8
Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO).导管原位癌(DCIS):患者报告结局(PRO)的重要性。
Curr Breast Cancer Rep. 2020 Jun;12(2):90-97. doi: 10.1007/s12609-020-00363-2. Epub 2020 Apr 4.
9
Cancer Outcomes in DCIS Patients Without Locoregional Treatment.DCIS 患者未经局部区域治疗的癌症结局。
J Natl Cancer Inst. 2019 Sep 1;111(9):952-960. doi: 10.1093/jnci/djy220.
10
Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review.乳腺癌生存者与不良心理健康结局之间的关联:系统评价。
J Natl Cancer Inst. 2018 Dec 1;110(12):1311-1327. doi: 10.1093/jnci/djy177.